The CHMP’s recommendation will be reviewed by the European Commission (EC), which is expected to make its final decision soon. Pfizer and BioNTech have already initiated manufacturing of the ...

Among healthy adults receiving the JN.1- or KP.2-adapted mRNA seasonal COVID-19 vaccine, neutralizing antibody responses were similar.

The mRNA vaccines approved to treat COVID-19 are safe and effective and show promise in treating other diseases including ...

The study also reviews the great potential of mRNA vaccines to treat influenza, RSV, cancer, and autoimmune diseases.

COVID-19 vaccine maker BioNTech (BNTX) has conducted confidential discussions with prospective bidders regarding plans to shutter manufacturing locations in Germany, German business daily Handelsblatt ...

When Pfizer Inc. and BioNTech SE’s Covid-19 vaccine rolls off production lines, Shanghai Fosun Pharmaceutical Group Co. will be waiting to distribute it through a complex and costly system of ...

A comprehensive new review published in The Lancet affirms that currently approved mRNA vaccines are safe and highly ...

Billions of doses later, a global review has found that mRNA vaccines are safe and highly effective. Not only have they ...

B.C.’s globally competitive biotech sector is pushing forward with more UBC-spin-off companies that harness both research and ...

A review of billions of mRNA vaccine doses finds strong COVID protection across groups, with rare serious side effects ...

There are a total of 153 patients hospitalized with COVID-19 at Ascension Sacred Heart in Pensacola. The number of ...

Your resource for the hottest moving stocks and news. We cover all sectors and markets giving everyday investors access to ...